pm mfvt1
    • Main page
      • About journal
      • Articles. Working with contents
      • Editor-in-chief
      • Editorial Council
      • Editorial Board


      • For authors
      • Standards for formatting information
      • Reviewing
      • Politics editorial board
      • Ethics of journal publications


      • For advertisers
      • Subscription
      • About the Publishing House
      • Contact us
  • Paroxysmal disorders of non-epileptic genesis with multiple sclerosis

    Редактор | 2018, Articles based on dissertstions, Practical medicine part 16 №06 (18) Gynecology | 1 октября, 2018

    S.R. SHAKIRZYANOVA1,2, G.M. AKHMEDOVA1,2, M.A. YAKUPOV1,2

    1Republic Clinical Neurologic Centre of the Tatarstan Ministry of Healthcare, 13 Vatutin Str., Kazan, Russian Federation, 420021

    2Kazan State Medical Academy, 36 Butlerov Str., Kazan, Russian Federation, 420012

     Shakirzyanova S.R. ― post-graduate student of the Department of Neurology and Manual Therapy, tel. (843) 278-23-17, e-mail: sofi.shakirzyanova@yandex.ru

    Akhmedova G.M. ― Cand. Med. Sc., Associate Professor of the Department of Neurology and Manual Therapy, tel. (843) 278-97-28, e-mail: guzel29@mail.ru

    Yakupov M.A. ― post-graduate student of the Department of Neurology and Manual Therapy, tel. (843) 278-23-17, e-mail: yaku-marat@yandex.ru

    Paroxysmal disorders of non-epileptic genesis with multiple sclerosis remain an insufficiently studied topic. The study objective was to study the main clinical and anamnestic, neurophysiological and neuroimaging characteristics of paroxysmal disorders of non-epileptic genesis caused by focal lesions of the central nervous system due to multiple sclerosis. Patients and methods: 101 patients with confirmed diagnosis of MS were examined. They were divided into two groups: group 1 ― 51 patients with paroxysmal impairment of non-epileptic genesis, group 2 ― without paroxysmal disturbances. Anamnestic data were collected; the patients underwent a clinical examination; visual evoked potential (VEP), transcranial magnetic stimulation (TMS), somato-sensoric evoked potentials (SEP), long latent reflexes (LLR) and magnetic-resonance tomography (MRI) was performed. Results and conclusions: The prevalence of non-epileptic paroxysms among patients with MS in RT was 8.3%. Anamnestic data, differences in neurophysiological data as compared to the control group were determined, and the relationship between focal CNS lesion and non-epileptic paroxysmal phenomena was revealed.

    Key words: demyelinating diseases, multiple sclerosis, paroxysmal disorders, neurophysiology.

    (For citation: Shakirzyanova S.R., Akhmedova G.M., Yakupov M.A. Paroxysmal disorders of non-epileptic genesis with multiple sclerosis. Practical Medicine. 2018)

    REFERENCES

    1. Khaybullin T.I. Pathogenetic heterogeneity of MS: the key to understanding the clinical polymorphism of the disease and the development of individualized therapy. Nevrologicheskiy vestnik, 2010, vol. 43 (iss. 1.), pp. 54–65 (in Russ.).
    2. Murray T.L. Multiple sclerosis: the history of a disease. NY: Demos, 2005. 594 p.
    3. Vlasov Ya.V. Rehabilitation process for multiple sclerosis: complexity, continuity, efficiency. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Rasseyannyy skleroz. Prilozhenie k zhurnalu, 2003, spec. issue 2, pp. 103–110 (in Russ.).
    4. Karnaukh V.N. Analysis of disability in multiple sclerosis. Sibirskiy meditsinskiy zhurnal, 2011, vol. 100, pp. 115–117 (in Russ.).
    5. Tatarinova M.Yu. Quality of life of patients with multiple sclerosis on the background of various treatment regimens. Vestnik Rossiyskogo gosudarstvennogo meditsinskogo universiteta, 2008, vol. 6, pp. 48–52 (in Russ.).
    6. Ionova T.I. Study of the quality of life in patients with MS. Nevrologicheskiy vestnik. Zhurnal im. V.M. Bekhtereva, 2010, vol. 42, pp. 88–94 (in Russ.).
    7. Khabirov F.A. The relevance of the automation of pharmacoeconomic analysis of the use of drugs in the treatment of multiple sclerosis. Obshchestvennoe zdorovʹe i zdravookhraneniya, 2011, vol. 4, pp. 68–69 (in Russ.).
    8. Safiullin R.S. Organization of medical and medicinal care for patients with multiple sclerosis in the Republic of Tatarstan. Vestnik Roszdravnadzora, 2012, vol. 2, 46–48 (in Russ.).
    9. Gusev E.I. Klinicheskie rekomendatsii. Nevrologiya i neyrokhirurgiya [Clinical guidelines. Neurology and neurosurgery]. Moscow: “GEHOTAR–Media”, 2007. 368 p.
    10. Bitsch A., Bruck W. Differentiation of multiple sclerosis subtypes: implications for treatment. CNS Drugs, 2002, 16 (6), pp. 405–418.
    11. Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics, 2008, 60, pp. 275–286.
    12. Tuzun E., Akman-Demir G., Eraksoy M. Paroxysmal attacks in multiple sclerosis. MultScler., 2001, vol. 7 (6), pp. 402–404.

    Метки: 2018, demyelinating diseases, G.M. AKHMEDOVA, M.A. YAKUPOV, multiple sclerosis, neurophysiology, paroxysmal disorders, Practical medicine part 16 №06 (18) Gynecology, S.R. SHAKIRZYANOVA

    ‹ Pulmonary arterial hypertension as one of variants of heart-vascular diseases associated with HIV-infection Clinical and epidemiological characteristics and treatment of Raynaud’s phenomenon in rheumatic diseases ›
    • rus Версия на русском языке


      usa English version site


      Find loupe

      

    • PARTNERS

      пов  logonew
    «Для
    Practical medicine. Scientific and practical reviewed medical journal
    All rights reserved ©